Kiora Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

Non-controlling interests (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2015

Dec. 31, 2014

Shares issuable upon the conversion of non-controlling interests as of December 31, 2014 are as follows:

Series B convertible preferred stock			525,004
Series C convertible preferred stock			187,183
Series D convertible preferred stock			358,146
			1,070,333

Shares issuable from the conversion of non-controlling interests are as follows:

	Year Ended December 31,
	2014		2013
Series B convertible preferred stock		525,004		525,004
Series C convertible preferred stock		187,183		187,183
Series D convertible preferred stock		358,146		358,146
		1,070,333		1,070,033